SAN DIEGO, AUGUST 13, 2018. (GLOBE NEWSWIRE). Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an innovative, next-generation suite of pre-clinical oncology services.
PALO ALTO, Calif.–(BUSINESS WIRE)–Science Exchange, the leading marketplace for outsourced R&D™, announces a collaboration with Reveal Biosciences to offer on-demand access to AI-based pathology services worldwide. Reveal Biosciences is a San Diego-based company that’s leading the next generation
CASE STUDY Cancer R&D researchers have adopted the use of immunohistochemistry (IHC) tests for research, prognostic and diagnostic use at an extremely fast rate (1). Despite these statistics, many antibody vendors targeting these researchers do
CASE STUDY Researchers have adopted the use of immunohistochemistry (IHC) tests for research, prognostic and diagnostic use at an extremely fast rate (1). There are over 3 million commercially available antibodies; however, in a Nature
Reveal Biosciences utilizes artificial intelligence (A.I.) to develop highly accurate and scalable pathology diagnostic tools which have a significant impact on drug discovery, precision medicine, and clinical trials. Watch this video to learn about Reveal
On June 21st, 2018, LaunchBio San Diego organized an event entitled “How AI Will Change Funding Opportunities for Biotech Entrepreneurs”. Sponsors of the event were The City of San Diego, Procopio, Biolabs, and Hughes Marino.
Scientists know that selecting good antibodies can often be a challenge. Many antibodies don’t work equally well for all applications (immunohistochemistry (IHC), immunofluorescence (IF), immunoprecipitation (IP), ELISA, Western blot etc.), and with a limited research
IHC is routinely automated using instruments such as the Leica Bond, Ventana BenchMark or Tissue-Tek Genie. These instruments are offered by their manufacturers together with a range of Ready-to-Use (RTU) antibodies and predefined protocols for
Reveal is happy to announce it has been accepted into the NVIDIA Inception Program. NVIDIA is the leading provider of GPU technology that is fueling the deep learning-based AI revolution. Reveal is using NVIDIA driven